Keywords: Forest, Almirall, Aclidinium, COPD, USA, FDA, General manager Germany

Forest and Almirall see early filing of COPD drug aclidinium with US FDA; Appointment at Almirall

Article | 04 July 2011

Print This

Spain’s largest pharma company Almirall (ALM. MC) and US marketing partner Forest Laboratories (NYSE: FRX) revealed on Friday ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in